$44.99
Research Studies:
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
CJC-1295 DAC 5mg is a synthetic growth hormone-releasing hormone (GHRH) analog known for its extended half-life due to Drug Affinity Complex (DAC) technology. This modification allows for sustained GH release, making it a critical tool in metabolic and performance-based research. Our CJC-1295 DAC is synthesized to the highest purity standards, ensuring reliable results for scientific studies.
CJC-1295 DAC 5mg is a valuable research peptide for studies focused on growth hormone modulation, metabolic enhancement, and recovery optimization.
| CAS No. | 863288-34-0 |
|---|---|
| Purity | ≥99% |
| Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Gln-Ser |
| Molecular Formula | C165H269N47O46 |
| Molecular Weight | 3647.20 g/mol |
| Applications | Growth hormone modulation, muscle growth research, metabolic studies |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months. |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy CJC-1295 DAC online should evaluate CJC-1295 DAC as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, purity documentation, batch-specific COAs, lot traceability, product labeling, storage information, and supplier evaluation. This guide explains how to evaluate CJC-1295 DAC for controlled research procurement through Pure Lab Peptides while keeping the discussion limited to laboratory research documentation and RUO sourcing.
Researchers can buy CJC-1295 DAC online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase “buy CJC-1295 DAC online” is addressed here as laboratory research procurement intent, not personal-use intent. In an RUO context, the commercial search is not about obtaining instructions, outcomes, or clinical guidance. It is about evaluating whether a supplier presents the compound as a controlled laboratory research material with documentation that can be reviewed before procurement.
Qualified researchers and technical procurement teams should focus on documentation rather than promotional language. Relevant review points include RUO labeling, batch-specific certificate of analysis availability, CJC-1295 DAC purity documentation, CJC-1295 DAC identity testing, lot number consistency, product form, storage information, and supplier transparency. This approach also helps distinguish legitimate research-procurement language from content that attempts to convert published literature into product-use claims.
In practice, an RUO procurement review should answer several narrow questions before any purchase decision is recorded. Does the product page identify the full compound name and amount? Does the COA correspond to the lot being supplied? Does the supplier present the material as a laboratory research compound rather than a wellness, therapy, or performance product? Are purity and identity supported by analytical terminology instead of unsupported assurances? These questions keep the search query inside a research purchasing workflow.
RUO positioning is especially important for research peptides because published literature may discuss a compound, receptor family, or analytical detection method in settings that are outside product procurement. FDA guidance for RUO and IUO in vitro diagnostic products explains that research-use labeling is tied to non-diagnostic laboratory research rather than clinical diagnostic use, which is a useful boundary concept for procurement teams reviewing RUO language even when the material being evaluated is not an IVD product [1].
CJC-1295 DAC is discussed in scientific and analytical literature as a modified analog of growth hormone-releasing hormone, commonly abbreviated GHRH, with a drug affinity complex associated with albumin binding in research descriptions. PubChem identifies CJC-1295 as a peptide compound record and lists chemical identifiers used for database-level compound recognition [2]. Early research described CJC-1295 as a tetrasubstituted hGRF(1-29) analog with an added maleimido-containing lysine derivative at the C terminus, selected as a long-lasting GRF analog in experimental work [3].
For research procurement, the most relevant point is not pathway interpretation. The relevant point is identity. A CJC-1295 DAC research material should be evaluated by the compound name, documented product form, lot-specific COA, stated purity, and analytical method information. Documentation may include molecular formula, molecular weight, sequence or structural identifiers where available, chromatographic data, mass data, and lot-level matching between the product label and the COA.
The term DAC should also be treated as a documentation term, not a casual label. Researchers should confirm that the product page, label, and COA all refer to CJC-1295 DAC rather than a similarly named GHRH analog or a non-DAC variant. Similar names can create procurement ambiguity when a laboratory record needs to identify exactly which research material entered inventory. A clear supplier record reduces that ambiguity by aligning the product title, compound description, amount, lot number, and analytical documentation.
CJC-1295 DAC falls within the GHRH analog and secretagogue-related research category. Research-safe discussion may reference GHRH pathway literature, receptor signaling literature, peptide analog research, compound identity, analytical documentation, COA review, and supplier documentation. Pathway relevance in published literature does not establish product-use guidance for RUO materials.
The GHRH receptor is described by UniProt as a receptor for growth hormone-releasing factor coupled to G proteins that activate adenylyl cyclase, while NCBI Gene identifies GHRHR as the gene encoding the growth hormone-releasing hormone receptor [4] [5]. These database entries provide research context for receptor nomenclature; they do not provide instructions for handling or applying any RUO material.
Researchers search buy CJC-1295 DAC to compare RUO product availability, supplier documentation, and pre-procurement quality signals. In a laboratory context, the search is typically about whether the supplier clearly identifies the compound, provides a batch-specific CJC-1295 DAC COA, states a purity claim with supporting data, and avoids language that suggests clinical, consumer, or veterinary use.
The online procurement process should also make it practical to review the product page, compare lot numbers, confirm whether CJC-1295 DAC is supplied as lyophilized powder, and record storage and handling information in internal laboratory records. For technical buyers, supplier transparency is not a marketing preference. It is part of a repeatable procurement workflow that supports traceability, audit readiness, and research planning.
Commercial search results can mix research suppliers, general informational pages, and pages that use non-research language. A qualified laboratory buyer should filter those results by documentation quality. RUO-safe supplier pages should avoid promises, personal instructions, clinical positioning, and unsupported pathway claims. The strongest pages make it easy to find the product identity, purity claim, COA status, amount, form, and supplier policies without asking the reader to infer use cases from literature.
Published analytical literature also explains why online sourcing should be paired with documentation review. Studies involving CJC-1295 and related GHRH analogs have used LC-MS/MS, LC-HRMS/MS, immunoaffinity purification, and other specialized approaches to identify or detect these peptides in research or anti-doping analytical contexts [6] [7]. These methods reinforce a basic procurement principle: a product name alone is not a complete identity review.
Researchers evaluating where to buy CJC-1295 DAC online for laboratory research should treat the product page, COA, and labeling language as a combined documentation package. Analytical guidance such as ICH Q2(R2) emphasizes that analytical procedure validation should demonstrate that a procedure is suitable for its intended purpose, while ICH Q14 describes science- and risk-based approaches for developing and maintaining analytical procedures suitable for assessing quality [8] [9].
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review the available batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data where available | Helps confirm the material matches the listed compound |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids dosing, therapeutic, or personal-use claims | Supports research-use-only positioning |
A CJC-1295 DAC COA should be reviewed as batch-level documentation, not as a generic marketing attachment. Researchers should look for compound name, lot number, test date, stated purity percentage, testing method, identity confirmation, molecular weight where relevant, chromatogram or mass data where available, product form, and storage documentation. A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together.
Lot-level review is a standard quality concept across regulated laboratory and manufacturing settings. For example, 21 CFR 211.84 describes lot-based sampling, testing, examination, and quality control release concepts for components in pharmaceutical manufacturing, while ICH Q7 discusses supplier qualification and certificate-of-analysis review for API-related materials [10] [11]. RUO peptide procurement is not the same as drug manufacturing, but the same documentation logic helps research teams review identity, lot traceability, and supplier transparency.
Analytical methods matter because peptide identity can be supported in different ways. HPLC may support purity assessment, LC-MS may support mass-based identity review, and tandem mass spectrometry can support targeted peptide confirmation in specialized workflows. FDA bioanalytical guidance and ICH M10 both discuss chromatographic methods used with mass spectrometry in analytical settings, supporting the general importance of method suitability and validation for quantitative or confirmatory data [12] [13].
When a COA lists an analytical method, researchers should not treat the method name as a substitute for review. They should examine whether the method supports the specific question being asked. For example, purity assessment and identity confirmation are related but different documentation needs. A chromatographic purity value can show the relative area of a major peak under defined conditions, while mass-based identity information can help connect the observed signal to the expected peptide mass. Both are stronger when tied to the same batch and lot number.
Published literature has examined CJC-1295 in GHRH analog research, receptor-pathway research, controlled clinical study settings, preclinical model settings, and analytical detection settings. Early experimental work identified CJC-1295 as a long-lasting GRF analog [3]. Controlled clinical literature examined pharmacokinetic and pharmacodynamic features of CJC-1295 in healthy adult study participants, while a separate study reported that pulsatile GH secretion persisted during continuous stimulation by a long-acting GHRH analog [14] [15].
Preclinical research also appears in the literature. A study in a GHRH knockout mouse model described CJC-1295 as a synthetic GHRH analog that binds endogenous albumin after administration in that model, and another serum-proteomics study examined profile changes associated with the GH/IGF-1 axis after CJC-1295 exposure in a controlled research setting [16] [17]. These publications provide scientific context only.
Published clinical literature should not be interpreted as use guidance for RUO materials. Likewise, preclinical model findings and pathway discussions should not be converted into product claims. The laboratory procurement question is narrower: whether the research material is documented, labeled, traceable, and supported by analytical data. Pathway relevance in published literature does not establish product-use guidance for RUO materials.
Analytical literature is particularly relevant to CJC-1295 DAC supplier evaluation because it focuses on detection, identity, and method development rather than product outcomes. Memdouh and colleagues investigated in vitro metabolism and detection of GHRH synthetic analogs including CJC-1295 and CJC-1295 with drug affinity complex by UHPLC-MS/MS methods [6]. Knoop and colleagues developed an LC-HRMS/MS method for qualitative identification of GHRH analogs in plasma, and Timms and colleagues described LC-MS/MS confirmation of CJC-1295 after immunoaffinity capture and tryptic digestion in a specialized analytical context [7] [18]. Henninge and colleagues also reported the identification of CJC-1295 in an unknown pharmaceutical preparation, emphasizing the role of analytical verification when product identity is uncertain [19]. These sources support the emphasis on identity testing, method transparency, and careful documentation review.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, sequence, formula, or classification | Database / analytical | Supports identification, not product-use claims |
| Pathway or category context | GHRH receptor, peptide analog classification, and model-specific research area | Review / in vitro / preclinical | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, and batch verification | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form and handling considerations | Laboratory documentation | Supports research workflow planning |
Research teams should also consider the stability and storage information associated with a supplier’s documentation. ICH Q1A(R2) describes stability testing as a way to understand how quality varies under environmental factors such as temperature, humidity, and light, and to support defined storage conditions in regulated product contexts [20]. For RUO procurement, that principle supports a practical recordkeeping point: storage instructions should be documented and followed according to the supplier’s RUO documentation.
The evidence landscape should be read conservatively. Database records help with nomenclature and identifiers. Analytical papers help explain the kinds of methods used to identify or detect related peptides. Pathway and clinical papers help define scientific vocabulary, but they should not be used as sales claims. A research procurement guide should therefore give more weight to COA review, identity support, and traceability than to claims about expected biological outcomes.
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “CJC-1295 DAC is discussed in published research related to GHRH analog and receptor-pathway research.” | Describes literature context without making a product claim | “CJC-1295 DAC helps with a human outcome.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy CJC-1295 DAC for results.” |
| “Pure Lab Peptides supplies CJC-1295 DAC as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies CJC-1295 DAC for therapy.” |
| “The phrase buy CJC-1295 DAC online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy CJC-1295 DAC online for personal use.” |
| “CJC-1295 DAC supplier documentation should identify lot number, method, and purity data.” | Centers the discussion on traceability and analytical review | “Supplier claims can replace analytical documentation.” |
Pure Lab Peptides presents CJC-1295 DAC research-use-only product details for laboratory research procurement. The CJC-1295 DAC 5mg product is positioned as a research-use-only material with a stated ≥99% purity claim, lyophilized powder form, available batch-specific COA, product page documentation, storage and handling information, lot-level traceability, and supplier transparency.
Review the Pure Lab Peptides CJC-1295 DAC product page for RUO labeling, product details, purity information, and batch-specific documentation. Researchers comparing broader peptide procurement options can also review the Pure Lab Peptides research peptide collection, the Pure Lab Peptides blogs, and shipping and returns information as part of supplier evaluation.
Supplier documentation should complement, not replace, internal laboratory review. NIST resources for proteomics performance metrics describe the importance of monitoring variability in liquid chromatography, mass spectrometric sampling, and peptide identification workflows, and NIST peptide tandem mass spectrum libraries are described as resources for direct peptide identification and validation of peptide identifications [21] [22]. These references support the broader point that peptide identity review depends on method-aware documentation.
For Pure Lab Peptides procurement review, the practical workflow is straightforward: start with the CJC-1295 DAC 5mg product page, confirm RUO positioning, review the available batch-specific COA, record the stated ≥99% purity claim and lyophilized powder form, and retain storage and handling information with internal purchasing records. The article does not provide instructions for application or preparation of the material; it is limited to supplier documentation and RUO procurement review.
Buy CJC-1295 DAC online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, and supplier transparency.
Published literature may examine CJC-1295, GHRH analogs, receptor context, or analytical detection methods, but those publications do not create instructions for RUO materials. Research literature context should be treated as scientific background, not as a product-use claim or procurement shortcut.
CJC-1295 DAC purity documentation is important, but purity alone does not establish complete identity. Researchers should review the compound name, lot number, method, mass or chromatographic data where available, and product-form consistency together before recording the material in laboratory procurement files.
A generic COA is less useful than a batch-specific COA because it may not correspond to the exact lot being procured. Researchers should match the lot number on the product label, product page, and COA so that CJC-1295 DAC supplier documentation supports traceability.
RUO labeling does not support clinical, diagnostic, personal, or veterinary positioning. It indicates that the material is intended for laboratory research use only. Procurement teams should avoid suppliers that blur this boundary through outcome claims, instructions, or non-research positioning.
Researchers can buy CJC-1295 DAC online for laboratory research from an RUO supplier that provides clear labeling, product documentation, purity information, identity support, storage information, and a batch-specific COA. Pure Lab Peptides provides a CJC-1295 DAC 5mg product page for research-focused procurement review.
Before buying CJC-1295 DAC online, researchers should check RUO labeling, the batch-specific COA, purity documentation, identity testing, lot number consistency, product form, storage guidance, and supplier language. The supplier should avoid clinical, consumer, veterinary, dosing, or therapeutic positioning.
A COA matters when buying CJC-1295 DAC because it provides batch-level documentation for identity and purity review. Researchers should confirm that the COA matches the product lot and includes relevant analytical method information, rather than relying only on product-page claims.
CJC-1295 DAC discussed here is not intended for human or animal consumption. It is addressed only as a research-use-only laboratory material for qualified researchers and technical procurement teams evaluating compound identity, COA documentation, purity data, and supplier transparency.
Research use only means CJC-1295 DAC is positioned for controlled laboratory research and documentation review, not consumer, clinical, diagnostic, veterinary, or therapeutic use. RUO procurement should emphasize compound identity, batch-specific documentation, lot traceability, storage information, and clear supplier boundaries.
Published literature about CJC-1295 DAC should be interpreted as scientific context, not as product-use guidance for RUO materials. Clinical, preclinical, receptor, or analytical studies can help researchers understand terminology and evidence type, but procurement decisions should focus on labeling, COA, identity, purity, and traceability.
For research teams comparing CJC-1295 DAC suppliers, prioritize COA availability, transparent labeling, purity documentation, CJC-1295 DAC supplier documentation, and lot-level traceability. Review the CJC-1295 DAC product page for RUO labeling, purity information, product form, storage details, and available batch-specific documentation before selecting any research-use-only material.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.